FAM40A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.101000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.635610E-01
Normal-vs-Stage2
6.004400E-03
Normal-vs-Stage3
5.779800E-02
Normal-vs-Stage4
2.366200E-01
Stage1-vs-Stage2
4.984200E-01
Stage1-vs-Stage3
6.412000E-02
Stage1-vs-Stage4
9.799400E-01
Stage2-vs-Stage3
9.372300E-02
Stage2-vs-Stage4
5.970200E-01
Stage3-vs-Stage4
8.622400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.523400E-03
Normal-vs-AfricanAmerican
1.468360E-01
Normal-vs-Asian
5.603700E-02
Caucasian-vs-AfricanAmerican
7.233800E-01
Caucasian-vs-Asian
8.397600E-01
AfricanAmerican-vs-Asian
6.906400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.043910E-02
Normal-vs-Female
2.776800E-01
Male-vs-Female
8.584200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.864800E-01
Normal-vs-Age(41-60Yrs)
3.386600E-01
Normal-vs-Age(61-80Yrs)
7.597900E-03
Normal-vs-Age(81-100Yrs)
2.407800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.419600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.776400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.473840E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.102700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.011900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.173000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.172040E-02
Normal-vs-Daily Drinker
2.463700E-02
Normal-vs-Weekly Drinker
3.068400E-02
Normal-vs-Occasional Drinker
3.090200E-01
Normal-vs-Social Drinker
5.740200E-02
Non Drinker-vs-Daily Drinker
3.289800E-01
Non Drinker-vs-Weekly Drinker
8.826000E-01
Non Drinker-vs-Occasional Drinker
1.375590E-01
Non Drinker-vs-Social Drinker
9.768300E-02
Daily Drinker-vs-Weekly Drinker
4.974000E-01
Daily Drinker-vs-Occasional Drinker
5.891000E-01
Daily Drinker-vs-Social Drinker
4.112800E-01
Weekly Drinker-vs-Occasional Drinker
2.365600E-01
Weekly Drinker-vs-Social Drinker
1.797190E-01
Occasional Drinker-vs-Social Drinker
7.069200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.334200E-01
Normal-vs-Grade 2
7.632200E-01
Normal-vs-Grade 3
7.629800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.228400E-01
Grade 1-vs-Grade 3
4.477400E-01
Grade 1-vs-Grade 4
5.334200E-01
Grade 2-vs-Grade 3
9.918400E-01
Grade 2-vs-Grade 4
7.632200E-01
Grade 3-vs-Grade 4
7.629800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.721600E-03
Normal-vs-NonDiabetic
2.685400E-01
Diabetic-vs-NonDiabetic
3.471600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.641800E-02
Normal-vs-NoPancreatitis
4.957400E-03
Pancreatitis-vs-NoPancreatitis
4.246800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.588260E-02
Normal-vs-N1
6.142600E-03
N0-vs-N1
7.969800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.292600E-01
Normal-vs-TP53-NonMutant
3.254400E-02
TP53-Mutant-vs-TP53-NonMutant
7.495800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
